Skip to content

Vervaardiging van farmaceutische grondstoffen

NACE 21100
Active companies, 5-year failure rate, regional split and recent bankruptcies for this NACE sector.
671 active companies with this primary NACE
Active companies671
Bankruptcies (5y)3
Failure rate0.45%
Regions covered4
Provinces covered11

Bankruptcies and the failure rate are attributed by each company's current primary NACE, not the NACE at the time of bankruptcy (which the gazette does not record).

Sector key figures

fiscal year 2024 · median over 46 filed annual accounts (NACE division 21)
Median solvency
46.9%
Median equity
€108k
Median net result
€-1k
Annual accounts in sample
46
Source: NBB annual accounts, all schema types combined. Medians computed internally.

Regional split

by region
Vlaanderen 72 · 50.7%
Wallonië 53 · 37.3%
Brussel 14 · 9.9%
Unknown 3 · 2.1%

Recent bankruptcies in this sector

3
Date Company
10-03-2026 Amalus Therapeutics
BE 0803.929.268
27-10-2025 UNIZIMA
BE 0744.643.759
06-12-2023 NEWCOM SERVICES
BE 0537.404.744

Geographic distribution

by province · based on the establishment address
fewer moremax 21